FEG
CHRS icon

Financial Enhancement Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Financial Enhancement Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,482
Closed -$26K – 280
2020
Q4 		$26K Buy
+1,482
New +$26K 0.01% 165